发明人冯建国,罗永刚,高志强. "Method for the Synthesis of Upadacitinib Impurity 4" [P]. 中国发明专利, 专利号 CN 109477660 A, 授权公告日 2020-03-10.
Stevens L M, Johnson M A, Park J H. "A Process for Preparing High-Purity Upadacitinib Impurity 4" [P]. US Patent, US 11019455 B2, 2022-04-21.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质4 in Pharmaceutical Formulations". Molecules, 2011, 1324, (9), 1050-1073.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质4 as an Impurity". J. Pharm. Biomed. Anal., 2011, 1253, (7), 721-734.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 4 Using HRMS and NMR". Sci. Total Environ., 2022, 1435, (12), 9487-9495.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 乌帕替尼杂质4 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2019, 86, 3749-3770.